NCT03456778

Brief Summary

The purpose of this study is to utilize Shear Wave Elastography (SWE) to study the viscoelastic properties of tendons to understand the functional differences between normal/asymptomatic and symptomatic tendon states. The study will also assess the degree of tendon healing following standard of care treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
2mo left

Started Feb 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Feb 2018Jul 2026

Study Start

First participant enrolled

February 27, 2018

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 2, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 7, 2018

Completed
8.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

August 14, 2025

Status Verified

July 1, 2025

Enrollment Period

8.3 years

First QC Date

March 2, 2018

Last Update Submit

August 11, 2025

Conditions

Keywords

Sonographic imagingShear Wave Elastography

Outcome Measures

Primary Outcomes (6)

  • Viscoelastic Tendon Property

    Shear wave elastography imaging will be used to establish baseline measurements of viscoelastic properties of tendons, such as the Achilles, patellar, quadriceps, epicondylar, and rotator cuff, among asymptomatic and symptomatic patients.

    Baseline

  • Change in Tendon Healing

    The degree of tendon healing among symptomatic patients receiving standard of care treatment will be assessed by examining stiffness changes measured by shear wave imaging.

    Baseline, Month 3, Month 6, Month 12

  • Change in Victorian Institute of Sport Assessment - Achilles (VISA-A) Score

    Participants symptomatic for Achilles tendinopathy who received standard of care treatment will be asked to complete the VISA-A scale. The VISA-A scale assesses the severity of chronic Achilles tendinopathy. This 8-item, self-administered questionnaire asks about Achilles tendon pain, daily living function, and sporting activity. Total scores can range from 0 to 100, with 0 representing worst pain and function and 100 signifying no pain or limitations to function. Scores below 70 indicate the presence of Achilles tendinopathy.

    Month 6, Month 9, Month 12

  • Change in Victorian Institute of Sport Assessment - Patellar Tendon (VISA-P) Score

    Participants symptomatic for patellar tendinopathy who received standard of care treatment will be asked to complete the VISA-A scale. The VISA-P scale assesses patellar tendinosis. This 8-item, self-administered questionnaire asks about symptoms, pain, function, and sporting activity. Total scores can range from 0 to 100, with 0 representing worst pain and function and 100 signifying no pain or limitations to function.

    Month 6, Month 9, Month 12

  • Change in The Foot & Ankle Disability Index (FADI) Score

    The FADI is a self-report instrument assessing function related to the foot and ankle. The FADI has 26 items that are scored on a 5-point scale where 0 = unable to do and 4 = no difficulty at all. Total raw scores range from 0 to 104 and scores are converted to percentages, where 100% indicates no dysfunction. This instrument is administered to symptomatic patients receiving standard of care treatment.

    Month 6, Month 9, Month 12

  • Change in The Foot & Ankle Disability Index (FADI) Sport Score

    The FADI Sport is a self-report instrument assessing function related to the foot and ankle in athletes. The FADI Sport has 8 items that are scored on a 5-point scale where 0 = unable to do and 4 = no difficulty at all. Total raw scores range from 0 to 32 and scores are converted to percentages, where 100% indicates no dysfunction. This instrument is administered to symptomatic patients receiving standard of care treatment.

    Month 6, Month 9, Month 12

Study Arms (2)

Shear Wave Elastography for Asymptomatic Volunteers

Patients with extremity pain but without tendon involvement will have tendon imagining using shear wave elastography.

Device: Shear Wave Elastography

Shear Wave Elastography Symptomatic Volunteers

Patients diagnosed with tendinopathy will have tendon imagining using shear wave elastography. Participants may have the option to have repeated imaging to examine tendon healing for up to a year after receiving standard of care treatment.

Device: Shear Wave Elastography

Interventions

An ultrasound (US) technique, known as shear wave elastography (SWE), is used to examine structure and biomechanical function. The examination takes place in the ultrasound room at the study site and lasts for approximately 20 minutes.

Shear Wave Elastography Symptomatic VolunteersShear Wave Elastography for Asymptomatic Volunteers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at the Emory Orthopaedics and Spine Center who are asymptomatic or symptomatic for tendinopathy.

You may qualify if:

  • Patients presenting at the study location with lower extremity pain without tendon involvement
  • Patients presenting at the study location with a clinical diagnosis of tenalgia
  • Diagnosis of tendinopathy confirmed by ultrasound

You may not qualify if:

  • Pregnancy
  • History of tendinopathy or surgery and morphologic abnormalities
  • History of systemic, metabolic, endocrine diseases, or psoriasis
  • History of treatment with corticosteroids, estrogens, long term quinolone antibiotics, and cholesterol drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Orthopaedics and Spine Center

Atlanta, Georgia, 30329, United States

RECRUITING

MeSH Terms

Conditions

Tendinopathy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and Injuries

Study Officials

  • David Reiter, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Reiter, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 2, 2018

First Posted

March 7, 2018

Study Start

February 27, 2018

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

August 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations